CS Diagnostics Financials

CSDX

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

This page shows CS Diagnostics (CSDX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).

Key Financial Metrics

Export CSV

Revenue

N/A

EBITDA

N/A

Free Cash Flow

N/A

Net Income

$761

CS Diagnostics reported $761 in net income in fiscal year 2025.

EPS (Diluted)

N/A

Cash & Debt

$501

CS Diagnostics held $501 in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

137M

CS Diagnostics had 137M shares outstanding in fiscal year 2025.

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

0.0%

CS Diagnostics's ROE was 0.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity.

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

CSDX Income Statement

Metric	FY25
Revenue	N/A
Cost of Revenue	N/A
Gross Profit	N/A
R&D Expenses	N/A
SG&A Expenses	N/A
Operating Income	N/A
Interest Expense	N/A
Income Tax	N/A
Net Income	$761
EPS (Diluted)	N/A

Metric	Q3'25	Q3'24	Q3'24
Revenue	$23K	N/A	$8K
Cost of Revenue	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A
R&D Expenses	$0	N/A	N/A
SG&A Expenses	$70	N/A	$70
Operating Income	-$182	N/A	$536
Interest Expense	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A
Net Income	-$182	N/A	$536
EPS (Diluted)	$0.00	N/A	$0.00

CSDX Balance Sheet

Metric	FY25
Total Assets	$499.4M
Current Assets	$501
Cash & Equivalents	$501
Inventory	N/A
Accounts Receivable	N/A
Goodwill	N/A
Total Liabilities	$1K
Current Liabilities	N/A
Long-Term Debt	N/A
Total Equity	$499.4M
Retained Earnings	-$4.8M

Metric	Q3'25	Q3'24	Q3'24
Total Assets	$499.4M0.0%	$499.4M	N/A
Current Assets	$31K+6090.2%	$501	N/A
Cash & Equivalents	$13-97.4%	$501-98.8%	$42K
Inventory	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A
Total Liabilities	$2K+12.7%	$1K	N/A
Current Liabilities	N/A	N/A	N/A
Long-Term Debt	N/A	N/A	N/A
Total Equity	$499.4M0.0%	$499.4M	N/A
Retained Earnings	-$4.7M+0.7%	-$4.8M	N/A

CSDX Financial Ratios

Metric	FY25
Gross Margin	N/A
Operating Margin	N/A
Net Margin	N/A
Return on Equity	0.0%
Return on Assets	0.0%
Current Ratio	N/A
Debt-to-Equity	0.00
FCF Margin	N/A

Metric	Q3'25	Q3'24	Q3'24
Gross Margin	N/A	N/A	N/A
Operating Margin	-0.8%	N/A	6.7%
Net Margin	-0.8%	N/A	6.7%
Return on Equity	N/A	N/A	N/A
Return on Assets	0.0%	N/A	N/A
Current Ratio	N/A	N/A	N/A
Debt-to-Equity	0.000.0	0.00	N/A
FCF Margin	N/A	N/A	N/A

Similar Companies

Guided Thera GTHP

$22.5M

Biotricity Inc BTCY

$14.3M

Perimeter Medical Imaging Ai Inc PYNKF

$19.0M

Aurora Spine ASAPF

$15.5M

PharmChem, Inc. PCHM

$17.3M

Frequently Asked Questions

Is CS Diagnostics profitable?

Yes, CS Diagnostics (CSDX) reported a net income of $761 in fiscal year 2025.

What is CS Diagnostics's return on equity (ROE)?

CS Diagnostics (CSDX) has a return on equity of 0.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What are CS Diagnostics's total assets?

CS Diagnostics (CSDX) had $499.4M in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does CS Diagnostics have outstanding?

CS Diagnostics (CSDX) had 137M shares outstanding as of fiscal year 2025.

What is CS Diagnostics's debt-to-equity ratio?

CS Diagnostics (CSDX) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is CS Diagnostics's return on assets (ROA)?

CS Diagnostics (CSDX) had a return on assets of 0.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.